This case underscores the importance of considering autoimmune encephalitis in young patients presenting with new-onset psychosis, in the apparent absence of malignancy, and a high index of suspicion and early CSF evaluation can prevent diagnostic delay and improve patient outcomes.
Abstract
Background
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an autoimmune disorder that frequently presents with prominent psychiatric manifestations, often leading to misdiagnosis as a primary psychiatric illness. Early recognition is critical, as timely immunotherapy significantly improves outcomes.
CASE PRESENTATION
A 26-year-old previously healthy man presented with acute psychosis following significant emotional stress and first-time marijuana use 3 days earlier. Initially diagnosed with brief psychotic disorder, he developed catatonia and fever. Cerebral spinal fluid (CSF) and serum anti-NMDA receptor antibodies confirmed the diagnosis. His course was complicated by bilateral pulmonary emboli and drug-induced liver injury. Treatment with intravenous immunoglobulin (IVIG) and high-dose corticosteroids resulted in marked improvement. Malignancy work-up was negative.
Conclusion
This case underscores the importance of considering autoimmune encephalitis in young patients presenting with new-onset psychosis, in the apparent absence of malignancy. A high index of suspicion and early CSF evaluation can prevent diagnostic delay and improve patient outcomes.
Anti‐N‐methyl‐D‐aspartate receptor (anti‐NMDAR) encephalitis frequently presents with prominent psychiatric symptoms, often mimicking primary psychiatric disorders and posing a significant diagnostic challenge. We report the case of a 33‐year‐old woman who presented with a 10‐day history of acute behavioral and psychia...
Bhumika Ghimire, Jagat Bhatt, Saugat Niraula et al.· Clinical Case Reports· 0 citations
Rationale: Autoimmune encephalitis in children often presents with neuropsychiatric symptoms and seizures and may progress to secondary epilepsy with prolonged functional impairment. Immunotherapy is the principal disease-modifying treatment, whereas comprehensive nursing care supports safety, complication prevention,...
Anti-N-methyl-D-aspartate receptor encephalitis frequently presents with isolated psychiatric symptoms indistinguishable from primary psychosis, delaying diagnosis. The authors have described a previously healthy 35-year-old woman admitted with abrupt first-episode psychosis, who (within 48 hours and without seizures,...
M. Basta, C. Bikis, A. Miliaras et al.· The Permanente Journal· 0 citations
Background Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis often requires intensive care and rapid escalation of immunotherapy. We report a critically ill woman with refractory anti-NMDAR encephalitis treated with tocilizumab (TCZ) as early second-line therapy and discuss the rationale for IL-6 receptor bl...
Renato Pierre Lima, J. Ferreira, Marcos Vinícius Tadao Fujino et al.· Frontiers in Immunology· 0 citations
Anti-N-methyl-d-aspartate (NMDA) receptor encephalitis is an autoimmune condition often characterized by acute neuropsychiatric manifestations, including psychiatric symptoms, seizures, autonomic instability, and cognitive dysfunction. Early diagnosis and treatment are crucial for improving patient outcomes. This repor...
Aaron Adams, Elizabeth A. Farabee, Chelsae Nugent et al.· Case Reports in Women's Heal...· 0 citations
Background Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is the commonest form of autoimmune encephalitis of childhood. However, little information is captured with formal neuropsychological testing. When the pre-illness history is incomplete, it is also hard to judge how much of the residual picture reflects...
Felipe Dalvi-Garcia, Iolanda de Salles Fonseca Carvalho, Julia Valeriano de Almeida et al.· Brain, Behavior, & Immunity...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.